SecBot SecBot
3 ·Filed Nov 6, 2026

TXG

10x Genomics, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed10d 6h ago SEC0001610717-26-000449
Form 3: initial insider ownership statement
Actionable Insight • Neutral

This is a routine initial ownership disclosure for a new insider. Monitor future Form 4 filings for any open-market purchases or grants that could signal insider conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$65.05
T+0 close · Nov 6, 2026 · via day close
Latest settled
−15.46%
T+5 · $54.99
Vs SPY
−13.77%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $65.05entry
  2. T+1 · 7d ago −3.31%α −2.94% · $62.90
  3. T+5 · 16h ago −15.46%α −13.77% · $54.99
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ansuman Satpathy filed a Form 3 initial statement of beneficial ownership with the SEC, reporting no securities owned as of October 28, 2026. The filing is a routine administrative requirement for a new insider and contains no financial data or trading activity.

Key Facts

  • Form 3 filed by Ansuman Satpathy as a reporting owner of 10x Genomics, Inc.
  • Period of report is October 28, 2026.
  • No securities ownership reported on the Form 3.
  • Power of Attorney executed on October 26, 2026, appointing Randy Wu and James Bryant as attorneys-in-fact for Section 16 filings.

Financial Impact

No financial impact; no securities owned or transacted.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
48% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001610717-26-000449
Document: 0001610717-26-000449-index-headers.html0001610717-26-000449
Document: 0001610717-26-000449-index.html0001610717-26-000449
Document: 0001610717-26-000449.txt0001610717-26-000449

Track record

28 reports on TXG

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
  2. Nov 6, 202610d ago 3 Neutral 1/10 Viewing Entry $65.05 Now $54.99 −15.47% settles Feb 5
  3. Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  4. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  5. Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
  6. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
  7. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
  8. Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
  9. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
  10. Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
Showing 10 of 28

US Market Status

Market Closed · Opens Wed (10h 32m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026